|
|
|
|
| 專題 |
最後回覆 |
暱稱 |
內容 |
| 聖諾醫藥 |
2023-10-09T12:33 |
財經茄呢啡 |
從事RNA藥物開發的聖諾醫藥（2257）旗下施用於鱗狀細胞原位癌（isSCC）的臨床研究腫瘤候選藥STP705，正邁向商業化階段，料需時兩年左右落實商業化。 |
|
|
|
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window